JPH01143827A - Capsule - Google Patents
CapsuleInfo
- Publication number
- JPH01143827A JPH01143827A JP62302417A JP30241787A JPH01143827A JP H01143827 A JPH01143827 A JP H01143827A JP 62302417 A JP62302417 A JP 62302417A JP 30241787 A JP30241787 A JP 30241787A JP H01143827 A JPH01143827 A JP H01143827A
- Authority
- JP
- Japan
- Prior art keywords
- film
- capsule
- parts
- sheath
- membrane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 38
- 238000007789 sealing Methods 0.000 claims abstract description 4
- 239000012528 membrane Substances 0.000 claims description 30
- 239000000853 adhesive Substances 0.000 claims description 16
- 230000001070 adhesive effect Effects 0.000 claims description 16
- 239000002356 single layer Substances 0.000 claims description 5
- 239000010410 layer Substances 0.000 claims description 4
- 239000010409 thin film Substances 0.000 claims description 3
- 239000003814 drug Substances 0.000 abstract description 6
- 230000002093 peripheral effect Effects 0.000 abstract description 6
- 229940079593 drug Drugs 0.000 abstract description 5
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000010408 film Substances 0.000 description 16
- 108010010803 Gelatin Proteins 0.000 description 9
- 239000008273 gelatin Substances 0.000 description 9
- 229920000159 gelatin Polymers 0.000 description 9
- 235000019322 gelatine Nutrition 0.000 description 9
- 235000011852 gelatine desserts Nutrition 0.000 description 9
- 239000007788 liquid Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 239000007901 soft capsule Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000005538 encapsulation Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 1
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 229920001807 Urea-formaldehyde Polymers 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- -1 farcelan Polymers 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000005011 phenolic resin Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Edible Oils And Fats (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
W10型乳化液、香料等の液状油、又は粉末、辱粒、錠
剤等の固形物並びにエキス、化粧水、乳液、調味液、水
性薬液等の水性液及び有機溶剤等を封入するためのソフ
トカプセルに関するものである。[Detailed description of the invention] (Industrial application field) W10 type emulsions, liquid oils such as fragrances, solid substances such as powders, granules, tablets, extracts, lotions, milky lotions, seasoning liquids, aqueous medicinal liquids, etc. The present invention relates to soft capsules for enclosing aqueous liquids, organic solvents, etc.
(従来の技Ifi)
カプセル皮膜を貼り合わせ、カプセルの成形と充填を行
う従来のカプセル製造方法に於いては、カプセル皮膜を
ロータリ一方式又は平板方式の二つの成型金型の圧切熱
接着により該カプセルを打ち抜きながら該皮膜の切断面
で直接接合させていたため、カプセル皮膜の膜厚(切断
面)が薄い場合は接着が難かしく、又接着しても接着力
が弱いためカプセル強度が低く、内容液が漏洩するとい
う欠点があった。(Conventional Technique Ifi) In the conventional capsule manufacturing method in which capsule membranes are bonded together and capsules are formed and filled, the capsule membrane is bonded by pressure cutting between two molding molds, either a rotary one-way type or a flat plate type. Since the capsules were directly joined at the cut surface of the membrane while punching out the capsules, it was difficult to adhere if the thickness of the capsule membrane (cut surface) was thin, and even if the capsule was adhered, the adhesive strength was weak, resulting in low capsule strength and the content. The problem was that the liquid leaked.
例えば、カプセルの充填時の皮膜の厚さは従来法でも略
0.4mm位までは薄くできるが、0.6〜1.5mm
が標準であり、皮膜を充填時0.4mm以下、乾燥時0
.2mm以下位まで薄くしてのカプセル化は従来の切断
面に於ける接着法では難かしい状況である。 又、カプ
セル皮膜の基剤には、ゼラチン(タンパク質)が最も一
般に使われているが、ゼラチンは水にとけるため、水の
カプセル化は不可能であった。 同様にゼラチン基剤で
はタンパク質と反応する物質、有機酸、低沸点の物質等
はカプセル化が困難であった。 しかしゼラチンカプセ
ル皮膜内面に耐水性の樹脂あるいは化学的に安定な物質
をコーティングする事等により多層性の皮膜にすれば、
ゼラチンカプセルとして充填できる。 黙しながらこの
場合、従来の切断面による接着法では、皮膜の各層を対
になるように、圧切・熱接着することは困難で、ゼラチ
ン以外の適当な膜基剤が少ないこともあり、多層性のソ
フトカプセルは製品化されていない。For example, the thickness of the film when filling capsules can be reduced to about 0.4 mm using conventional methods, but it can be reduced to 0.6 to 1.5 mm.
is standard, 0.4 mm or less when filled with film, 0 when dry
.. Encapsulation at a thickness of 2 mm or less is difficult with conventional bonding methods on cut surfaces. Furthermore, gelatin (protein) is most commonly used as a base for capsule membranes, but since gelatin dissolves in water, it has been impossible to encapsulate water. Similarly, it is difficult to encapsulate substances that react with proteins, organic acids, substances with low boiling points, etc. using gelatin base. However, if you create a multilayered film by coating the inner surface of the gelatin capsule film with a water-resistant resin or a chemically stable substance,
Can be filled as gelatin capsules. However, in this case, it is difficult to press-cut and heat-bond each layer of the film in pairs using the conventional adhesion method using cut surfaces, and there are few suitable film bases other than gelatin, so it is difficult to create a multilayer structure. Soft capsules have not been commercialized.
(技術的課題)
而して、本発明は従来技術の欠点に鑑みなされたもので
、カプセルの接着縁部での強度を向上せしめると共に、
膜自体を薄くすることが出来、体内での薬剤等の放出を
スムースに行なわしめカプセルの崩壊性を速めること並
びに多層性の皮膜により従来はカプセル化が困難であっ
た水性液等のカプセル化を図ることを技術的課題とする
ものである。(Technical Problem) The present invention has been made in view of the shortcomings of the prior art, and aims to improve the strength of the adhesive edge of the capsule, and
The membrane itself can be made thinner, allowing for smooth release of drugs, etc. within the body and speeding up capsule disintegration, and the multi-layered membrane allows for the encapsulation of aqueous liquids, etc., which were previously difficult to encapsulate. The technical challenge is to achieve this goal.
(技術的手段)
本発明では、上記の技術的課題を解決するために圧着乃
至ヒートシールに基いて接合する接着面縁部を外周方向
へ突出して鍔部を形成せしめることによって該鍔部同志
の貼着面積を広くしたものである。(Technical Means) In order to solve the above-mentioned technical problem, in the present invention, a flange is formed by protruding the edge of the adhesive surface to be joined based on pressure bonding or heat sealing toward the outer periphery, so that the flange can be separated from each other. It has a wider adhesion area.
具体的には図示(第1図乃至第8図)に示す如く下記の
構成となる。Specifically, as shown in the drawings (FIGS. 1 to 8), the configuration is as follows.
第一の実施例(第1図乃至第3図)について。Regarding the first embodiment (FIGS. 1 to 3).
lOはゼラチン、グリセリン、水等を主たる成分とし、
又、一定範囲の含水率を維持して成る皮膜にて形成し、
楕円体形状をしたカプセル本体であり、その封入内容物
11は主に油性液、粉末懸濁油、ペースト状油、W10
型乳化液等である。The main components of IO are gelatin, glycerin, water, etc.
In addition, it is formed with a film that maintains a moisture content within a certain range,
The capsule body has an ellipsoidal shape, and the enclosed contents 11 are mainly oily liquid, powder suspension oil, paste oil, W10
Type emulsion etc.
12は楕円体形を半分にした上側皮膜であり、その外周
縁部13を外方向へ断面が略△となる如く縁付状にすべ
く鍔部14を形成せしめである。Reference numeral 12 designates an upper membrane having an ellipsoidal shape in half, and a flange 14 is formed on the outer peripheral edge 13 of the membrane so that the outer peripheral edge 13 has a border shape so that the cross section becomes approximately △ in the outward direction.
15は前記鍔部14の貼着面である。Reference numeral 15 indicates an adhesive surface of the flange portion 14.
16は楕円体形を半分にした形状の下側皮膜であり、そ
の外周縁部17を外方向へ断面が略Vとなる如く縁付状
にすべく鍔部18を形成せしめである。Reference numeral 16 denotes a lower membrane having a shape obtained by halving an ellipsoid, and a flange 18 is formed on the outer peripheral edge 17 of the lower membrane so that the cross section becomes approximately V-shaped in the outward direction.
19は前記鍔部18の貼着面である。Reference numeral 19 indicates an adhesive surface of the flange portion 18.
20は前記貼着面(15,19)同志を対向接着して出
来た接着部分であり、全体形状が断面略0状の縁材形状
となるようにしである。Reference numeral 20 denotes an adhesive portion formed by adhering the adhesive surfaces (15, 19) facing each other, and the overall shape is a border material shape with a substantially zero cross section.
又、本実施例は単一層の薄い皮膜にて形成してあり、前
記鍔部(14,18)の形成によって貼着面積を広くす
ることが出来るようにしであるので例えば封入内容物の
充填時の皮膜の厚さ略0.4mm程度の薄さであっても
接着可能であり、カプセル本体lOの崩壊性を速め得、
カプセル本体10の接着強度も向上する。In addition, this embodiment is formed with a single layer of thin film, and the formation of the flanges (14, 18) allows for a wide adhesion area, so for example when filling the enclosed contents. Even if the film is as thin as approximately 0.4 mm, it can be bonded, and the disintegration of the capsule body IO can be accelerated.
The adhesive strength of the capsule body 10 is also improved.
(作 用) 上記の技術的手段は下記の如く作用する。(for production) The above technical means works as follows.
圧溶着する。この時両者(12,16)の外周縁部(1
3,17)を外方向へ縁付状に鍔部(14,18)を湾
曲形成する。 次いで、鍔部(14,18)の貼着面(
15,19)同志を対向させて圧力又はヒートシールに
より接着すれば良い。Pressure weld. At this time, the outer peripheral edge (1
3, 17), the flange portions (14, 18) are curved outward in an edged manner. Next, the adhesive surface (
15, 19) They may be placed facing each other and bonded together by pressure or heat sealing.
而して、単一の薄い皮膜であっても鍔部(14,18)
を形成しであるので、貼着面積を広く採ることが出来、
接着力を向上することが出来る。Therefore, even with a single thin film, the flange (14, 18)
Since it forms a large area of adhesive,
Adhesive strength can be improved.
然る時、そのカプセル本体10の全体形状は第1図に示
す如く縁付状の楕円体形状となる。At this time, the overall shape of the capsule body 10 becomes an ellipsoidal shape with edges as shown in FIG.
このように膜自体を薄くすることが出来るので、特に薬
剤に採用した場合、体内での溶解が容易となり薬剤の放
出をスムースに行い得る。Since the membrane itself can be made thin in this way, especially when used as a drug, it can be easily dissolved in the body and the drug can be released smoothly.
第二の実施例(第4図乃至第5図)について。Regarding the second embodiment (FIGS. 4 and 5).
尚、本実施例に於いて、第一の実施例と同じ部分には略
凹じ番号を附しである。In this embodiment, the same parts as in the first embodiment are given substantially recessed numbers.
未実施例の特徴は上側皮膜12と下側皮1916とを夫
々二重膜に形成せしめることにより、内容物に対するカ
プセル膜の機能・耐久性を高め、従来はカプセル化でき
なかった様な物質もカプセル化することにある。The feature of the unembodied example is that the upper skin 12 and the lower skin 1916 are formed into double membranes, thereby increasing the functionality and durability of the capsule membrane against the contents, and making it possible to encapsulate substances that could not be encapsulated in the past. It's about encapsulation.
即ちゼラチン、寒天、アルギン酸(塩)、プルラン、カ
ラギーナン、ファーセラン、セルロース誘導体、タマリ
ンドガム、ローカストビンガム、グアーガム等のカプセ
ル基剤から成る膜22と、これとは耐水性、耐薬物性、
通気性等物性(膜機能)の異なる膜、即ち、でんぷん類
、セルロース類、セラック、有機シリコン樹脂、β−ピ
ネン重合体、ポリ(メタ)アクリル酸とポリ(メタ)ア
クリル酸エステルの共重合体、フェノール樹脂・尿素樹
脂・エポキシ樹脂等の熱硬化性樹脂、紫外線硬化樹脂等
から成る内面膜21とを用い、膜機能の高い多層性ソフ
トカプセルを形成することを特徴とする点にある。That is, the membrane 22 is made of a capsule base such as gelatin, agar, alginic acid (salt), pullulan, carrageenan, farcelan, cellulose derivatives, tamarind gum, locust Bingham, or guar gum, and has water resistance, drug resistance,
Membranes with different physical properties (membrane functions) such as breathability, such as starches, cellulose, shellac, organic silicone resins, β-pinene polymers, copolymers of poly(meth)acrylic acid and poly(meth)acrylic acid ester The present invention is characterized in that a multilayer soft capsule with a high membrane function is formed by using an inner membrane 21 made of a thermosetting resin such as a phenol resin, a urea resin, or an epoxy resin, or an ultraviolet curing resin.
尚、膜の添加剤(可塑剤)としてはグリセリン、ソルビ
トール、マンニトール、ポリエチレングリコール等を使
用し、着色剤としては医薬品に許可されている水溶性色
素、酸化チタン、カラメル、雲母等を使用し、保存剤と
してはパラオキシ安息香酸のメチル、エチル、プロピル
エステル等を使用することが出来るのは従来のソフトカ
プセルと同様である。In addition, glycerin, sorbitol, mannitol, polyethylene glycol, etc. are used as additives (plasticizers) for the film, and water-soluble pigments permitted for pharmaceuticals, titanium oxide, caramel, mica, etc. are used as colorants. As with conventional soft capsules, methyl, ethyl, and propyl esters of paraoxybenzoic acid can be used as preservatives.
而して、封入内容物11が直接外面膜22と化学反応を
生じて該外面膜22を破損することがなく、又内面膜2
1の貼着部分20をも外面膜22によって保護されるの
で常に接着力が維持され、内面膜21を介しての封入内
容物11の外部への漏洩は全くない。Therefore, the enclosed contents 11 do not directly cause a chemical reaction with the outer membrane 22 and damage the outer membrane 22, and the inner membrane 2
1 is also protected by the outer membrane 22, the adhesive strength is always maintained, and there is no leakage of the enclosed contents 11 to the outside via the inner membrane 21.
即ち、従来のゼラチン基剤の単層のソフトカプセルでは
カプセル化できなかった水・アルコール等もカプセル化
出来る。That is, it is possible to encapsulate water, alcohol, etc., which could not be encapsulated with conventional gelatin-based single-layer soft capsules.
例えば、充填物が水の場合ではゼラチン単層膜では溶融
してしまい、又充填物がアルコールの場合ではゼラチン
単層膜では、アルコールが膜を通過し蒸散してしまい、
更に又、充填物が乳液の場合ではゼラチン単層膜では、
水分が膜に移行し、膜が軟化し、水分が蒸散してしまう
。For example, if the filling material is water, a gelatin single-layer film will melt, and if the filling material is alcohol, the alcohol will pass through the film and evaporate.
Furthermore, when the filler is an emulsion, a gelatin monolayer film has
Moisture transfers to the membrane, softens the membrane, and evaporates.
尚、本実施例に於いてカプセル本体lOを二重層膜状に
形成しであるが、これに限定されずに多重積層皮膜によ
って形成しても良く、その作用効果は二重層皮膜の場合
と略凹−である。In this embodiment, the capsule body 10 is formed into a double-layered film, but it is not limited to this, and may be formed with a multi-layered film, and its effects are approximately the same as those of a double-layered film. It is concave.
第三の実施例(第6図乃至第8図)について。Regarding the third embodiment (FIGS. 6 to 8).
尚、本実施例に於いて第一の実施例と略凹じ部分には略
凹じ番号を附しである。Incidentally, in this embodiment, substantially concave portions are given approximate concave numbers.
本実施例の特徴は縁付状にしたカプセル本体10の全体
形状を楕円体形の他に長楕円体形、球形、二連形等その
他種々の形状に応用せしめた点にあり、その具体的構成
に甚く作用効果は第一の実施例と略凹−である。The feature of this embodiment is that the overall shape of the rimmed capsule body 10 is applied to various shapes other than an ellipsoid, such as an elongated ellipsoid, a spherical shape, and a double shape. The operation and effect are substantially the same as those of the first embodiment.
(効 果)
而して、本発明は下記の如き特有の効果を有するもので
ある。(Effects) The present invention has the following unique effects.
特に、カプセル本体を縁付状に形成せしめたので、該カ
プセル本体の成型時での接着縁部での接着力を向上維持
せしめることが出来ると共に全体の皮膜の膜厚サイズを
極力薄くすることが出来る。In particular, since the capsule body is formed into a rimmed shape, it is possible to improve and maintain the adhesive force at the adhesive edge during molding of the capsule body, and the thickness of the entire film can be made as thin as possible. I can do it.
この為、封入内容物が漏洩するおそれは全然無く、皮膜
の溶解時間も早
く内容物の放出が容易であり、又カプセル皮膜の切断面
で接着する如き従来のカプセルで、多層性の皮膜を用い
る場合には各層を夫々対応する層同志の切断面で接着す
る必要があるので実際上は不可能であったが、本カプセ
ルではこの様な欠点を解消したものである。For this reason, there is no risk of the enclosed contents leaking out, and the dissolution time of the membrane is fast, making it easy to release the contents.Also, a multilayer membrane is used instead of a conventional capsule that adheres at the cut surface of the capsule membrane. In some cases, it would be necessary to bond each layer at the cut surfaces of the corresponding layers, which was practically impossible, but this capsule solves this drawback.
第1図乃至第3図は本発明品の第一の実施例を示すもの
であり、第1図はカプセル本体の全体斜視図、第2図は
第1図のx−X線部分の一部縦断側面図、第3図は鍔部
要部を示す拡大断面図である。
第4図乃至第5図は本発明品の第二の実施例を示すもの
で、第4図は一部縦断側面図、第5図は鍔部要部を示す
拡大断面図である。
第6図乃至第8図は第三の実施例を示すもので、第6図
は長楕円体形のカプセル本体の全体斜視図、第7図は球
形のカプセル本体の全体斜視図、第8図は二連形のカプ
セル本体の全体側面図である。
14.18・・・鍔部 15.19・・・貼着面20・
・・接着部分
特許出願人 富士カプセル株式会社1 to 3 show a first embodiment of the present invention, FIG. 1 is a perspective view of the entire capsule body, and FIG. 2 is a part of the section taken along the line x-X in FIG. 1. The vertical side view and FIG. 3 are enlarged sectional views showing the main parts of the collar. 4 and 5 show a second embodiment of the product of the present invention, in which FIG. 4 is a partially longitudinal side view, and FIG. 5 is an enlarged sectional view showing the main part of the collar. Figures 6 to 8 show the third embodiment, in which Figure 6 is an overall perspective view of an oblong capsule body, Figure 7 is an overall perspective view of a spherical capsule body, and Figure 8 is an overall perspective view of a spherical capsule body. FIG. 2 is an overall side view of a double-shaped capsule body. 14.18...Brim portion 15.19...Adhesion surface 20.
...Adhesive portion patent applicant Fuji Capsule Co., Ltd.
Claims (4)
部を外周方向へ突出して鍔部を形成せしめると共に、該
鍔部同志を対向接着して縁付形状にして成るカプセル(1) A capsule in which a flange is formed by protruding the adhesive surface portion that is bonded by pressure and heat sealing toward the outer periphery, and the flange portions are bonded facing each other to form a rimmed shape.
プセルが単一層の薄膜より成るカプセル(2) In the statement of claim 1, the capsule with a rim is made of a single-layer thin film.
プセルが二層以上の複層の膜より成るカプセル(3) In the statement of claim 1, the capsule with a rim is made of a multilayer membrane of two or more layers.
、縁付きカプセルの全体形状が楕円体形、長楕円体形、
球形、チューブ形、二連形等その他の形状に応用せしめ
たカプセル(4) In claims 1 to 3, the overall shape of the rimmed capsule is ellipsoidal, oblong,
Capsules applied to other shapes such as spherical, tube-shaped, double-shaped, etc.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62302417A JPH01143827A (en) | 1987-11-30 | 1987-11-30 | Capsule |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62302417A JPH01143827A (en) | 1987-11-30 | 1987-11-30 | Capsule |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH01143827A true JPH01143827A (en) | 1989-06-06 |
Family
ID=17908665
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62302417A Pending JPH01143827A (en) | 1987-11-30 | 1987-11-30 | Capsule |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH01143827A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0413610A (en) * | 1990-04-27 | 1992-01-17 | Conopco Inc | Capsule for cosmetic use |
US6340473B1 (en) | 1999-07-07 | 2002-01-22 | R.P. Scherer Technologies, Inc. | Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same |
JP2016104012A (en) * | 2010-02-22 | 2016-06-09 | ラブストアLabstore | Sealing of material to natural transport system |
-
1987
- 1987-11-30 JP JP62302417A patent/JPH01143827A/en active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0413610A (en) * | 1990-04-27 | 1992-01-17 | Conopco Inc | Capsule for cosmetic use |
US6340473B1 (en) | 1999-07-07 | 2002-01-22 | R.P. Scherer Technologies, Inc. | Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same |
US6582727B2 (en) | 1999-07-07 | 2003-06-24 | R. P. Scherer Technologies, Inc. | Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same |
USRE39079E1 (en) * | 1999-07-07 | 2006-04-25 | R.P. Scherer Technologies, Inc. | Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same |
JP2016104012A (en) * | 2010-02-22 | 2016-06-09 | ラブストアLabstore | Sealing of material to natural transport system |
US9795990B2 (en) | 2010-02-22 | 2017-10-24 | Incredible Foods, Inc. | Enclosing materials in natural transport systems |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI81495B (en) | HAEFTPLAOSTER. | |
US4928840A (en) | Tamper proof encapsulated medicaments | |
CA2338323C (en) | Two-piece capsule for receiving pharmaceutical preparations for powder inhalers | |
AU700873B2 (en) | Childproof blister package with dessicant | |
CN101969933B (en) | The combination of the oral drugs combined by coating | |
JP2010280679A (en) | Active ingredient support in the form of film | |
JP2005529645A (en) | Powder compression and coating | |
JPH02264715A (en) | Medicare system for administration via skin or mucilage of active substance and use thereof | |
JPH09510990A (en) | Topical dressing, method of making topical dressing and use of topical dressing | |
US5460824A (en) | Method for the preparation of an encapsulated medicament | |
MX2009002452A (en) | Packaging for films which contain active substances, and method for producing it. | |
CA2348843A1 (en) | A capsule based drug delivery system | |
KR20200090201A (en) | Pouch-type oral dissolution film with high concentration of active ingredient | |
JPH01143827A (en) | Capsule | |
JP2003514639A (en) | Method for encapsulating a topical composition | |
KR100659947B1 (en) | Packaging for a plaster containing active ingredients | |
JP5015704B2 (en) | Formulation package | |
WO2006005897B1 (en) | Capsules derived from asymmetrical production | |
JP4125304B2 (en) | Dispensing method of press-through pack and split tablet | |
CN205916562U (en) | Packing plant of structure agent is composed in freeze -drying | |
JP4596411B2 (en) | Easily destructible capsule and its product | |
JPS592686Y2 (en) | spice bag | |
CN220495141U (en) | Covering filling type wound dressing with medicine packaging function | |
TWI726298B (en) | A microcontainer and a system, method for high speed filling thereof | |
JPH09286462A (en) | Synthetic resin container |